Skip to content
10-Q

Quarterly Report

Adaptive Biotechnologies Corp ADPT

0000950170-25-103120

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 152.27M sh
Shares Diluted Q2 2025 · Jun 30, 2025 152.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 150.65M sh
Shares Diluted Q2 2025 · Jun 30, 2024 147.41M sh
Shares Diluted Q2 2025 · Jun 30, 2024 146.6M sh
Capex Q2 2025 · Jun 30, 2025 $1.91M
Capex Q2 2025 · Jun 30, 2024 $3.24M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$40.91M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$55.66M
Long Term Debt Q2 2025 · Jun 30, 2025 $130.5M
Long Term Debt Q2 2025 · Dec 31, 2024 $132.41M
Short Term Debt Q2 2025 · Jun 30, 2025 $3.07M
Short Term Debt Q2 2025 · Dec 31, 2024 $865K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $43.16M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $47.92M
Stockholders Equity Q2 2025 · Jun 30, 2025 $179.72M
Stockholders Equity Q2 2025 · Dec 31, 2024 $202.71M
Current Liabilities Q2 2025 · Jun 30, 2025 $92.14M
Current Liabilities Q2 2025 · Dec 31, 2024 $98.05M
Total Liabilities Q2 2025 · Jun 30, 2025 $317.1M
Total Liabilities Q2 2025 · Dec 31, 2024 $336.89M
Current Assets Q2 2025 · Jun 30, 2025 $261.86M
Current Assets Q2 2025 · Dec 31, 2024 $283.75M
Total Assets Q2 2025 · Jun 30, 2025 $496.64M
Total Assets Q2 2025 · Dec 31, 2024 $539.38M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.17
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.37
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.31
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.64
Eps Basic Q2 2025 · Jun 30, 2025 −$0.17
Eps Basic Q2 2025 · Jun 30, 2025 −$0.37
Eps Basic Q2 2025 · Jun 30, 2024 −$0.31
Eps Basic Q2 2025 · Jun 30, 2024 −$0.64
Sga Expense Q2 2025 · Jun 30, 2025 $17.79M
Sga Expense Q2 2025 · Jun 30, 2025 $35.19M
Sga Expense Q2 2025 · Jun 30, 2024 $17.9M
Sga Expense Q2 2025 · Jun 30, 2024 $37.49M
Rd Expense Q2 2025 · Jun 30, 2025 $24.13M
Rd Expense Q2 2025 · Jun 30, 2025 $48.34M
Rd Expense Q2 2025 · Jun 30, 2024 $25.35M
Rd Expense Q2 2025 · Jun 30, 2024 $55.6M
Net Income Q2 2025 · Jun 30, 2025 −$25.61M
Net Income Q2 2025 · Jun 30, 2025 −$55.47M
Net Income Q2 2025 · Jun 30, 2024 −$46.22M
Net Income Q2 2025 · Jun 30, 2024 −$93.73M
Operating Income Q2 2025 · Jun 30, 2025 −$25.04M
Operating Income Q2 2025 · Jun 30, 2025 −$54.64M
Operating Income Q2 2025 · Jun 30, 2024 −$47.32M
Operating Income Q2 2025 · Jun 30, 2024 −$96.08M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $18M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $34.98M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $19.32M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $37.37M
Revenue Q2 2025 · Jun 30, 2025 $58.88M
Revenue Q2 2025 · Jun 30, 2025 $111.32M
Revenue Q2 2025 · Jun 30, 2024 $43.19M
Revenue Q2 2025 · Jun 30, 2024 $85.06M